Quantcast

Latest Glycated hemoglobin Stories

Diabetes, Pre-Diabetes Cases Have Doubled Over Twenty Years
2014-04-16 03:00:23

Johns Hopkins Bloomberg School of Public Health Alarming Increases in Blacks, Hispanics and the Elderly; Obesity Partly to Blame Cases of diabetes and pre-diabetes in the United States have nearly doubled since 1988, suggests new research from the Johns Hopkins Bloomberg School of Public Health, with obesity apparently to blame for the surge. The researchers also found that the burden of the disease has not hit all groups equally, with alarming increases in diabetes in blacks, Hispanics...

2014-04-15 23:12:19

Avail is conducting a 6-week, Phase 2 randomized study to assess the safety, tolerability and pharmacodynamics of a new combination therapy administered to participants with type 2 diabetes mellitus. DeLand, FL (PRWEB) April 15, 2014 *To see if you qualify for this Diabetes Clinical Trial in DeLand, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost to participate, no insurance required, and you may receive...

2014-04-14 12:34:30

New Abbott test could help physicians diagnose people in the U.S. who are unaware that they have diabetes, empowering them to control their disease ABBOTT PARK, Ill., April 14, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that its new ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test - which can aid physicians in diagnosing and monitoring diabetes and identifying people at risk for the disease - has received 510(k) clearance from the U.S. Food and Drug...

2014-04-14 12:32:44

Conference Call and Webcast at 8:30 a.m. Eastern Time THE WOODLANDS, Texas, April 14, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today positive, top-line results in a Phase 2 clinical trial of LX4211 in type 1 diabetes, which achieved the primary endpoint of reducing mealtime insulin use as well as several secondary endpoints, including improved glycemic control. LX4211 is an oral, first-in-class, dual inhibitor of sodium glucose transporters 1 and 2...

2014-04-03 12:23:34

Sleep apnea has been linked with elevated blood sugar levels, suggesting people with the condition could be at an increased risk of cardiovascular illness and mortality. The findings of a new study, published online today (3 April 2014) in the European Respiratory Journal, add to a growing body of evidence that suggests that sleep apnea is linked with diabetes. The research analyzed 5,294 participants from the multinational European Sleep Apnoea Cohort. The researchers measured levels...

2014-04-01 08:28:59

-Promising first interim phase 3 data for ITCA 650 in type 2 diabetes, combined with robust execution against key milestones and the addition of key talent BOSTON, April 1, 2014 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced the completion of another landmark private round of equity financing for $200 million. Together with the $210 million round of equity and debt financing in November of 2012 the company is very strongly positioned for future milestones and launch...

2014-02-25 23:04:57

GIA announces the release of a comprehensive global report on Hemoglobin A1c Monitoring markets. Global market for Hemoglobin A1c Monitoring is projected to exceed US$2 billion by 2020 driven by the continuous rise in diabetic population worldwide, and the pressing need for diabetes management through continuous monitoring. San Jose, California (PRWEB) February 25, 2014 Follow us on LinkedIn - Hemoglobin A1c (HbA1c) monitoring is one of the rapidly growing markets in the diagnostics...

2014-02-22 23:01:14

Transparency Market Research Report added "Continuous Glucose Monitoring (CGM) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012 - 2018" to its database. Browse full report: http://www.transparencymarketresearch.com/continuous-glucose-monitoring.html. Albany, New York, USA (PRWEB) February 22, 2014 Continuous glucose monitoring systems are real-time monitoring systems for checking glucose levels in the body. The system consists of a tiny sensor...

2014-02-21 08:25:23

Trial Seeks to Examine the Effects of INVOKANA® on the Progression of Diabetic Nephropathy RARITAN, N.J., Feb. 21, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced the initiation of CREDENCE (Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation), a global, multicenter study of INVOKANA(®) (canagliflozin). This Phase 3 study is a randomized, double-blind, placebo-controlled, parallel group trial designed to enroll...

2014-02-12 08:28:48

In study, non-invasive lens autofluorescence was comparable to gold standard hemoglobin A1c and fasting plasma glucose tests to distinguish if a person had diabetes SAN DIEGO, Feb. 12, 2014 /PRNewswire/ -- Freedom Meditech today announced the publication of a study comparing measurement of lens autofluorescence to current hemoglobin A1c and fasting plasma glucose tests. Using a non-invasive six-second eye scan, researchers found a statistically significant difference in...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related